Dupont Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-517
| Closed | -$53.5K | – | 808 |
|
2022
Q4 | $53.5K | Sell |
517
-2,649
| -84% | -$274K | ﹤0.01% | 1053 |
|
2022
Q3 | $268K | Buy |
3,166
+1,333
| +73% | +$113K | 0.02% | 794 |
|
2022
Q2 | $152K | Buy |
1,833
+507
| +38% | +$42K | 0.01% | 1060 |
|
2022
Q1 | $102K | Buy |
1,326
+42
| +3% | +$3.23K | ﹤0.01% | 1253 |
|
2021
Q4 | $113K | Buy |
+1,284
| New | +$113K | ﹤0.01% | 1271 |
|
2021
Q3 | – | Sell |
-2,190
| Closed | -$183K | – | 1729 |
|
2021
Q2 | $183K | Hold |
2,190
| – | – | ﹤0.01% | 1320 |
|
2021
Q1 | $165K | Buy |
2,190
+307
| +16% | +$23.1K | ﹤0.01% | 1301 |
|
2020
Q4 | $165K | Sell |
1,883
-586
| -24% | -$51.3K | ﹤0.01% | 1165 |
|
2020
Q3 | $188K | Sell |
2,469
-8,370
| -77% | -$637K | ﹤0.01% | 1132 |
|
2020
Q2 | $1.34M | Sell |
10,839
-614
| -5% | -$75.7K | 0.03% | 414 |
|
2020
Q1 | $968K | Buy |
11,453
+4,371
| +62% | +$369K | 0.02% | 463 |
|
2019
Q4 | $599K | Buy |
7,082
+2,135
| +43% | +$181K | 0.01% | 752 |
|
2019
Q3 | $333K | Sell |
4,947
-1,175
| -19% | -$79.1K | 0.01% | 955 |
|
2019
Q2 | $524K | Sell |
6,122
-2,469
| -29% | -$211K | 0.01% | 763 |
|
2019
Q1 | $763K | Hold |
8,591
| – | – | 0.02% | 618 |
|
2018
Q4 | $732K | Buy |
8,591
+3,542
| +70% | +$302K | 0.02% | 620 |
|
2018
Q3 | $490K | Buy |
+5,049
| New | +$490K | 0.01% | 721 |
|
2018
Q2 | – | Sell |
-1,717
| Closed | -$139K | – | 981 |
|
2018
Q1 | $139K | Sell |
1,717
-146
| -8% | -$11.8K | ﹤0.01% | 854 |
|
2017
Q4 | $166K | Sell |
1,863
-3,900
| -68% | -$348K | ﹤0.01% | 804 |
|
2017
Q3 | $536K | Buy |
5,763
+3,900
| +209% | +$363K | 0.01% | 665 |
|
2017
Q2 | $169K | Sell |
1,863
-417
| -18% | -$37.8K | ﹤0.01% | 827 |
|
2017
Q1 | $200K | Hold |
2,280
| – | – | ﹤0.01% | 810 |
|
2016
Q4 | $189K | Buy |
+2,280
| New | +$189K | ﹤0.01% | 787 |
|